Literature DB >> 26908112

Aldosterone, Renin, and Diabetes Mellitus in African Americans: The Jackson Heart Study.

Joshua J Joseph1, Justin B Echouffo-Tcheugui1, Rita R Kalyani1, Hsin-Chieh Yeh1, Alain G Bertoni1, Valery S Effoe1, Ramon Casanova1, Mario Sims1, Adolfo Correa1, Wen-Chih Wu1, Gary S Wand1, Sherita H Golden1.   

Abstract

CONTEXT: Previous research has suggested that activation of the renin-angiotensin-aldosterone system may promote insulin resistance and β-cell dysfunction, but the association with incident diabetes in African Americans is unknown.
OBJECTIVE: We examined the association of aldosterone and renin with insulin resistance, β-cell function, and incident diabetes in a large African American cohort.
DESIGN: The Jackson Heart Study is a prospective study of the development and progression of cardiovascular disease in African Americans.
SETTING: Participants were recruited from the tricounty area of metropolitan Jackson, Mississippi. PARTICIPANTS: A total of 5301 African American adults, aged 21–94 years, were assessed at baseline and through 12 years of follow-up. Data on aldosterone, renin, and risk factors were collected at baseline (2000–2004). Diabetes (fasting glucose ≥ 126 mg/dL, physician diagnosis, use of diabetes drugs, or glycated hemoglobin ≥ 6.5%) was assessed at baseline and through 12 years of follow-up. Participants were excluded for missing data on baseline covariates or diabetes follow-up. Cox regression was used to estimate hazard ratios (HR) for incident diabetes using sequential modeling adjusting for age, sex, education, occupation, systolic blood pressure, current smoking, physical activity, dietary intake, and body mass index. EXPOSURES: Aldosterone, renin, and diabetes risk factors were measured. OUTCOME: Outcomes included the homeostatic model assessment of insulin resistance (HOMA-IR) and incident diabetes.
RESULTS: Among 3234 participants over a median of 8.0 years of follow-up, there were 554 cases of incident diabetes. Every 1% increase in log-transformed aldosterone was associated with a 0.18% higher log-transformed HOMA-IR in cross-sectional analyses of nondiabetic participants (P < .001). Log-transformed aldosterone and renin levels in the fifth vs first quintile were associated with a 78% (HR 1.78, 95% confidence interval 1.35–2.34) and 35% (HR 1.35, 95% confidence interval 1.06–1.72) increase in diabetes risk, respectively, in fully adjusted models.
CONCLUSIONS: Activation of the renin-angiotensin-aldosterone system may play a significant role in the development of insulin resistance and diabetes in African Americans.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26908112      PMCID: PMC4880170          DOI: 10.1210/jc.2016-1002

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  40 in total

1.  Dietary sodium, aldosterone, and left ventricular mass changes during long-term inhibition of the renin-angiotensin system.

Authors:  Guilhem du Cailar; Pierre Fesler; Jean Ribstein; Albert Mimran
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

2.  Laboratory, reading center, and coordinating center data management methods in the Jackson Heart Study.

Authors:  Myra A Carpenter; Richard Crow; Michael Steffes; William Rock; Jeffrey Heilbraun; Gregory Evans; Thomas Skelton; Robert Jensen; Daniel Sarpong
Journal:  Am J Med Sci       Date:  2004-09       Impact factor: 2.378

3.  Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement.

Authors:  Sherita Hill Golden; Arleen Brown; Jane A Cauley; Marshall H Chin; Tiffany L Gary-Webb; Catherine Kim; Julie Ann Sosa; Anne E Sumner; Blair Anton
Journal:  J Clin Endocrinol Metab       Date:  2012-06-22       Impact factor: 5.958

4.  Aldosterone production and insulin resistance in healthy adults.

Authors:  Rajesh Garg; Shelley Hurwitz; Gordon H Williams; Paul N Hopkins; Gail K Adler
Journal:  J Clin Endocrinol Metab       Date:  2010-02-03       Impact factor: 5.958

Review 5.  The effect of aldosterone on glucose metabolism.

Authors:  Dalila B Corry; Michael L Tuck
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

6.  Aldosterone excess impairs first phase insulin secretion in primary aldosteronism.

Authors:  Evelyn Fischer; Christian Adolf; Anna Pallauf; Cornelia Then; Martin Bidlingmaier; Felix Beuschlein; Jochen Seissler; Martin Reincke
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

7.  Correlates of urinary albumin excretion in young adult blacks and whites: the Coronary Artery Risk Development in Young Adults Study.

Authors:  Maureen A Murtaugh; David R Jacobs; Xinhua Yu; Myron D Gross; Michael Steffes
Journal:  Am J Epidemiol       Date:  2003-10-01       Impact factor: 4.897

8.  Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines.

Authors:  Christine Guo; Vincent Ricchiuti; Bill Q Lian; Tham M Yao; Patricia Coutinho; José R Romero; Jianmin Li; Gordon H Williams; Gail K Adler
Journal:  Circulation       Date:  2008-04-21       Impact factor: 29.690

Review 9.  Effects of aldosterone on insulin sensitivity and secretion.

Authors:  James M Luther
Journal:  Steroids       Date:  2014-09-04       Impact factor: 2.668

10.  Aldosterone, C-reactive protein, and plasma B-type natriuretic peptide are associated with the development of metabolic syndrome and longitudinal changes in metabolic syndrome components: findings from the Jackson Heart Study.

Authors:  Solomon K Musani; Ramachandran S Vasan; Aurelian Bidulescu; Jiankang Liu; Vanessa Xanthakis; Mario Sims; Ravi K Gawalapu; Tandaw E Samdarshi; Michael Steffes; Herman A Taylor; Ervin R Fox
Journal:  Diabetes Care       Date:  2013-06-11       Impact factor: 19.112

View more
  20 in total

1.  The association of morning serum cortisol with glucose metabolism and diabetes: The Jackson Heart Study.

Authors:  Robin Ortiz; Bjoern Kluwe; James B Odei; Justin B Echouffo Tcheugui; Mario Sims; Rita R Kalyani; Alain G Bertoni; Sherita H Golden; Joshua J Joseph
Journal:  Psychoneuroendocrinology       Date:  2018-12-27       Impact factor: 4.905

2.  Lack of Suppression of Aldosterone Production Leads to Salt-Sensitive Hypertension in Female but Not Male Balb/C Mice.

Authors:  Jessica L Faulkner; Daisy Harwood; Lily Bender; Lenee Shrestha; Michael W Brands; M Jane Morwitzer; Simone Kennard; Galina Antonova; Eric J Belin de Chantemèle
Journal:  Hypertension       Date:  2018-12       Impact factor: 10.190

3.  Serum potassium is a predictor of incident diabetes in African Americans with normal aldosterone: the Jackson Heart Study.

Authors:  Ranee Chatterjee; Clemontina A Davenport; Laura P Svetkey; Bryan C Batch; Pao-Hwa Lin; Vasan S Ramachandran; Ervin R Fox; Jane Harman; Hsin-Chieh Yeh; Elizabeth Selvin; Adolfo Correa; Kenneth Butler; David Edelman
Journal:  Am J Clin Nutr       Date:  2016-12-14       Impact factor: 7.045

4.  Aldosterone, Renin, Cardiovascular Events, and All-Cause Mortality Among African Americans: The Jackson Heart Study.

Authors:  Joshua J Joseph; Justin B Echouffo-Tcheugui; Rita R Kalyani; Hsin-Chieh Yeh; Alain G Bertoni; Valery S Effoe; Ramon Casanova; Mario Sims; Wen-Chih Wu; Gary S Wand; Adolfo Correa; Sherita H Golden
Journal:  JACC Heart Fail       Date:  2017-08-16       Impact factor: 12.035

5.  The Association of ARMC5 with the Renin-Angiotensin-Aldosterone System, Blood Pressure, and Glycemia in African Americans.

Authors:  Joshua J Joseph; Xiaofei Zhou; Mihail Zilbermint; Constantine A Stratakis; Fabio R Faucz; Maya B Lodish; Annabel Berthon; James G Wilson; Willa A Hsueh; Sherita H Golden; Shili Lin
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

6.  Ideal Cardiovascular Health, Cardiovascular Remodeling, and Heart Failure in Blacks: The Jackson Heart Study.

Authors:  Aferdita Spahillari; Sameera Talegawkar; Adolfo Correa; J Jeffrey Carr; James G Terry; João Lima; Jane E Freedman; Saumya Das; Robb Kociol; Sarah de Ferranti; Donya Mohebali; Stanford Mwasongwe; Katherine L Tucker; Venkatesh L Murthy; Ravi V Shah
Journal:  Circ Heart Fail       Date:  2017-02       Impact factor: 8.790

7.  The association of calcium channel blockers with β-cell function in type 2 diabetic patients: A cross-sectional study.

Authors:  Dong Zhao; Yu Cao; Cai-Guo Yu; Sha-Sha Yuan; Ning Zhang; Yuan-Yuan Zhang; Jan A Staessen; Ying-Mei Feng
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-03-22       Impact factor: 3.738

8.  Allostatic load in the association of depressive symptoms with incident coronary heart disease: The Jackson Heart Study.

Authors:  Shannon L Gillespie; Cindy M Anderson; Songzhu Zhao; Yubo Tan; David Kline; Guy Brock; James Odei; Emily O'Brien; Mario Sims; Sophie A Lazarus; Darryl B Hood; Karen Patricia Williams; Joshua J Joseph
Journal:  Psychoneuroendocrinology       Date:  2019-07-04       Impact factor: 4.905

9.  Obesity and the diagnostic accuracy for primary aldosteronism.

Authors:  Amit Tirosh; Fady Hannah-Shmouni; Charalampos Lyssikatos; Elena Belyavskaya; Mihail Zilbermint; Smita B Abraham; Maya B Lodish; Constantine A Stratakis
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-06-13       Impact factor: 3.738

10.  Primary Aldosteronism Decreases Insulin Secretion and Increases Insulin Clearance in Humans.

Authors:  Gail K Adler; Gillian R Murray; Adina F Turcu; Hui Nian; Chang Yu; Carmen C Solorzano; Robert Manning; Dungeng Peng; James M Luther
Journal:  Hypertension       Date:  2020-03-16       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.